RALEIGH – The RD Fund (Retinal Degeneration Fund), which is the venture arm of the Foundation Fighting Blindness, is among the investors in a $78 million venture funding round for California-based Perceive Biotherapeutics.
How much the Raleigh-based group invested was not disclosed.
For details, read the full announcement at: https://www.prnewswire.com/news-releases/the-retinal-degeneration-fund-invests-in-a-78m-series-b-for-perceive-biotherapeutics-301715147.html
Opus Genetics, launching from Raleigh-based Retinal Degeneration Fund, raises $19M
